ABBV · AbbVie, Inc.

265.78

USD

6.86 (2.65%)

19/08/2026 09:56:02 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$457.54B

96.80

EV/EBITDA

16.1

DIV Yield

2.9%

Payout Ratio

200%

MQV Rating

4Weak

As at 19/08/2026 09:56:02 AM

Price Chart

Description

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

All-Companies
All-Consensus
ALL-Recommendations
HALO 200
HALO 500
HALO All
HALO Capital Efficiency
Hammer Bullish (Realtime)
Recent Price upgrade

Key Fundamentals

EPS 3 yr Growth

-64.40%

EBITDA Margin

47.50%

Operating Cashflow

$19,030m

Free Cash Flow Return

31.50%

ROIC

6.90%

Interest Coverage

9.50

Quick Ratio

0.60

Performance

52 weeks range

Low 190.75 - 267.47

Trade Value (12mth)

US$360,967,855.00

1 week

0.95%

1 month

-1.2%

YTD

9.17%

1 year

21.18%

All time high

267.47

Additional Data

Shares Outstanding (Fully Diluted)

1,771m

HALO Sector

Healthcare

Next Company Report Date

03-Feb-27

Next Ex Dividend Date

15-Jul-26

Next Dividend Pay Date

14-Aug-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Strong

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Strong

Dividends

Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

Date	Event
19 August 26EDG
07 August 26EDG
06 August 26EDG
04 August 26EDG
04 August 26EDG

Key Stakeholders

Name	Title
Richard A. Gonzalez	Individual
Blue Sparrow LLC (Delaware)	Private Company
Azita Saleki-Gerhardt	Individual
Robert A. Michael	Individual
Employees Provident Fund	Pension Fund